3-Month Visual And Refractive Outcomes In Refractive Lens Exchange With Artiols®
Published 2025 - 43rd Congress of the ESCRS
Reference: PP10.14 | Type: Free paper | DOI: 10.82333/69jh-ma23
Authors: Mübeccel Bulut* 1 , ALİ HAKİM REYHAN 2
1Ophthalmology,Necip Fazıl City Hospital,Kahramanmaraş,Türkiye, 2Ophthalmology,Harran University, Faculty of Medicine,Şanlıurfa,Türkiye
Purpose
To report the three-month visual outcomes and Patient‐reported outcome measures (PROMs) of patients undergoing clear lens excahnge with the ArtIOLs®.
Setting
Methods
This retrospective, non-randomised, single-centre study analysed the efficacy and safety of the combination of ArtIOLs®40 (EDF) and ArtIOLs® 70 (FVR) lens in 10 patients who underwent refractive lens exchange (RLE) between December 2023 and February 2025. Follow-up examinations were conducted at least three months after treatment, including refraction and visual acuity at far, intermediate and near distances.
The subjects were selected from the existing patient pool of the eye clinic of the University Hospital Marburg. The eligible patients were identified by a review of the clinic's surgical reports. Relevant pre- and postoperative clinical data were systematically extracted from the written patient records, anonymised and analysed.
Results
The preop SEQ was +1.45 ± 0.70 (-0.88 to 2.74 D). Preop CDVA was 20/20 or better in 90 % of eyes. At least 3 months after surgery, postop accuracy of SEQ to intended showed 80 % of eyes within ±0.50 D and 100 % within ±1.00D. Binokular UDVA was 20/20 or better in 90 % and 20/25 or better in 100 % of eyes.
The binocular UNVA for 40 cm was 20/20 or better in 80 % and 20/25 or better in 90% of eyes and binokular UIVA for 66 cm 20/20 or better in 85 % and 20/25 or better in 90 % of eyes. All patients achieved spectacle independence for far and intermediate vision, with only one patient requiring usually glasses for near vision.
Conclusions